Cynosure Group’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.21M Buy
8,242
+7,446
+935% +$3.15M 0.48% 26
2026
Q1
$377K Sell
796
-214
-21% -$108K 0.05% 166
2025
Q4
$472K Sell
1,010
-82
-8% -$38.1K 0.05% 227
2025
Q3
$465K Hold
1,092
0.05% 222
2025
Q2
$418K Sell
1,092
-35
-3% -$12.6K 0.05% 253
2025
Q1
$389K Sell
1,127
-1,781
-61% -$573K 0.05% 166
2024
Q4
$873K Buy
2,908
+1,549
+114% +$541K 0.13% 85
2024
Q3
$552K Buy
1,359
+233
+21% +$85.3K 0.08% 141
2024
Q2
$362K Buy
1,126
+168
+18% +$54.6K 0.06% 314
2024
Q1
$320K Buy
+958
New +$293K 0.06% 243

Other funds holding HCA

Cynosure Group's HCA Position: Q2 2026 in Review

Cynosure Group increased its HCA Healthcare (HCA) stake by 935% in Q2 2026, buying an estimated $3.15M and bringing the position to 8,242 shares worth $3.21M. The position accounts for 0.48% of the portfolio, ranked #26.

Cynosure Group first reported a position in HCA in Q1 2024 and has held it in 10 quarters since. 1,339 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Cynosure Group held 8,242 shares of HCA Healthcare worth $3.21M as of Q2 2026.
  • Cynosure Group bought 7,446 HCA Healthcare shares in Q2 2026, an estimated $3.15M.
  • HCA Healthcare made up 0.48% of Cynosure Group's portfolio in Q2 2026, its #26 holding.
  • Cynosure Group first reported a position in HCA Healthcare in Q1 2024 and has held it in 10 quarters since.
  • 1,339 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Cynosure Group's 13F filing for Q2 2026, filed 5 Aug 2026.